Based: Marlborough, MA
Investors: Biotechonomy Ventures, Kleiner Perkins Caufield & Byers, Undisclosed Investor, VantagePoint Venture Partners
Scoop: Xcellerex raised $41.84 million in two separate rounds last year. During the first round in January, the company raised $11 million to finance commercialization of a manufacturing program that uses disposable components to produce multiple products. In another round in October, Xellerex gained $31 million for "development and commercialization of its proprietary FlexFactory manufacturing system and XDR bioreactors for the production of biomolecules, including biotherapeutics and vaccines, and for developing its own internal biomolecule products."
Xcellerex gains $11M in new venture funds. Report